Chromogranin  	Chromogranin  	 NNP	B-NP
A  	A  	 NNP	I-NP
( 	( 	 -LRB-	O
CgA 	CgA 	 NNP	B-NP
)  	)  	 -RRB-	O
-  	-  	 :	O
the  	the  	 DT	O
influence  	influence  	 NN	O
of  	of  	 IN	O
various  	various  	 JJ	O
factors  	factors  	 NNS	O
in  	in  	 IN	O
vivo  	vivo  	 NN	B-NP
and  	and  	 CC	O
in  	in  	 IN	O
vitro 	vitro 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
existing  	existing  	 VBG	B-NP
disorders  	disorders  	 NNS	I-NP
on  	on  	 IN	O
it 	it 	 PRP	O
's  	's  	 VBZ	O
concentration  	concentration  	 VBN	B-NP
in  	in  	 IN	O
blood  	blood  	 NN	B-NP
Chromogranin  	Chromogranin  	 NNP	I-NP
A  	A  	 NNP	O
( 	( 	 -LRB-	O
CgA 	CgA 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
regarded  	regarded  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
major 	major 	 JJ	O
,  	,  	 ,	O
nonspecific  	nonspecific  	 FW	B-NP
neuroendocrine  	neuroendocrine  	 FW	I-NP
tumour  	tumour  	 FW	I-NP
( 	( 	 -LRB-	O
NET 	NET 	 NNP	B-NP
)  	)  	 -RRB-	O
marker 	marker 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
results  	results  	 NNS	O
of  	of  	 IN	O
CgA  	CgA  	 JJ	B-NP
blood  	blood  	 NN	I-NP
concentration 	concentration 	 NN	I-NP
,  	,  	 ,	O
however 	however 	 RB	O
,  	,  	 ,	O
may  	may  	 MD	O
actually  	actually  	 RB	O
be  	be  	 VB	O
influenced  	influenced  	 VBN	O
by  	by  	 IN	O
various  	various  	 JJ	O
factors  	factors  	 NNS	O
or  	or  	 CC	O
coexisting  	coexisting  	 JJ	O
pathological  	pathological  	 JJ	B-NP
conditions 	conditions 	 NNS	I-NP
.  	.  	 .	O
Among  	Among  	 IN	O
the  	the  	 DT	O
factors  	factors  	 NNS	O
causing  	causing  	 VBG	O
a  	a  	 DT	O
substantial  	substantial  	 JJ	O
increase  	increase  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
blood  	blood  	 NN	O
CgA  	CgA  	 JJ	B-NP
concentration  	concentration  	 NNS	I-NP
are 	are 	 VBP	O
:  	:  	 :	O
treatment  	treatment  	 NN	O
with  	with  	 IN	O
proton-pump  	proton-pump  	 JJ	B-NP
inhibitors  	inhibitors  	 NN	I-NP
or  	or  	 CC	O
H2  	H2  	 CD	O
-receptor  	-receptor  	 JJ	O
blockers 	blockers 	 NN	O
,  	,  	 ,	O
chronic  	chronic  	 FW	B-NP
atrophic  	atrophic  	 FW	I-NP
gastritis  	gastritis  	 FW	I-NP
( 	( 	 -LRB-	O
type  	type  	 NN	O
A 	A 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
impaired  	impaired  	 VBN	O
renal  	renal  	 JJ	B-NP
function 	function 	 NN	I-NP
,  	,  	 ,	O
prostate  	prostate  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
and  	and  	 CC	O
BPH 	BPH 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
rheumatoid  	rheumatoid  	 JJ	B-NP
arthritis  	arthritis  	 NN	I-NP
with  	with  	 IN	O
high  	high  	 JJ	O
level  	level  	 NN	O
of  	of  	 IN	O
RF  	RF  	 NNP	B-NP
IgM 	IgM 	 NNP	I-NP
.  	.  	 .	O
In  	In  	 IN	O
addition 	addition 	 NN	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
sort  	sort  	 NN	O
of  	of  	 IN	O
investigated  	investigated  	 JJ	O
biological  	biological  	 JJ	B-NP
material  	material  	 NN	I-NP
( 	( 	 -LRB-	O
whether  	whether  	 IN	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
serum  	serum  	 VBN	B-NP
or  	or  	 CC	O
plasma 	plasma 	 CD	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
of  	of  	 IN	O
importance 	importance 	 NN	O
.  	.  	 .	O
There  	There  	 EX	O
are  	are  	 VBP	O
also  	also  	 RB	O
many  	many  	 JJ	O
conditions  	conditions  	 NNS	O
which  	which  	 WDT	O
may  	may  	 MD	O
have  	have  	 VB	O
a  	a  	 DT	O
moderate  	moderate  	 JJ	O
or  	or  	 CC	O
little  	little  	 JJ	O
influence  	influence  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
concentration  	concentration  	 NN	B-NP
of  	of  	 IN	I-NP
CgA 	CgA 	 NNP	I-NP
,  	,  	 ,	O
among  	among  	 IN	O
them  	them  	 PRP	O
are 	are 	 VBP	O
:  	:  	 :	O
inflammatory  	inflammatory  	 JJ	B-NP
bowel  	bowel  	 JJ	I-NP
disease  	disease  	 NN	I-NP
( 	( 	 -LRB-	O
ulcerative  	ulcerative  	 JJ	B-NP
colitis  	colitis  	 NN	I-NP
and  	and  	 CC	O
Crohn 	Crohn 	 NNP	O
's  	's  	 POS	O
disease 	disease 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
deteriorating  	deteriorating  	 VBG	B-NP
liver  	liver  	 JJ	I-NP
function 	function 	 NN	I-NP
,  	,  	 ,	O
untreated  	untreated  	 JJ	O
essential  	essential  	 JJ	B-NP
hypertension 	hypertension 	 NN	I-NP
,  	,  	 ,	O
heart  	heart  	 NN	B-NP
failure 	failure 	 NN	I-NP
,  	,  	 ,	O
hypercortisolism 	hypercortisolism 	 NN	B-NP
,  	,  	 ,	O
pregnancy 	pregnancy 	 NN	O
,  	,  	 ,	O
and 	and 	 CC	O
,  	,  	 ,	O
in  	in  	 IN	O
some  	some  	 DT	O
subjects 	subjects 	 NNS	B-NP
,  	,  	 ,	O
ingestion  	ingestion  	 NN	B-NP
of  	of  	 IN	O
a  	a  	 DT	O
meal 	meal 	 NN	O
.  	.  	 .	O
Proper  	Proper  	 JJ	B-NP
assessment  	assessment  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
CgA  	CgA  	 JJ	I-NP
results  	results  	 NNS	I-NP
requires  	requires  	 VBZ	O
detailed  	detailed  	 JJ	O
knowledge  	knowledge  	 NN	O
about  	about  	 IN	O
various  	various  	 JJ	O
factors 	factors 	 NNS	O
,  	,  	 ,	O
drugs 	drugs 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
pathological  	pathological  	 JJ	B-NP
conditions  	conditions  	 NNS	I-NP
influencing  	influencing  	 VBG	O
its  	its  	 PRP$	O
concentration  	concentration  	 NN	B-NP
in  	in  	 IN	O
blood 	blood 	 NN	O
.  	.  	 .	O
